Baker Brothers reports multiple common-stock sales (NASDAQ: TARA)

robot
Abstract generation in progress

Baker Brothers Life Sciences, L.P. has reported multiple sales of common stock in Protara Therapeutics (NASDAQ: TARA) via a Form 144 filing. The filing details several sale events in February and March 2026, totaling millions of dollars, with associated share counts. Jefferies LLC is also noted as an underwriter reference from September 2020.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin